Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function

Non-medicine Intervention Clinical Trial

Official title:

Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04513275
• Other study ID #: PLFSBC
• Status: Not yet recruiting
• Start date: October 1, 2020
• Est. completion date: September 30, 2022

Study information

• Verified date: August 2020
• Source: Shanghai Mental Health Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Chinese version of the cognitive function test of schizophrenia (MCCB) . To explore a predictive model for long-term medication use in patients based on cognitive function

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: September 30, 2022
• Est. primary completion date: September 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Schizophrenia patients with first episode and disease duration of 5, 10, 20, and 30 years _Meet the diagnostic criteria for schizophrenia in ICD-10

Exclusion Criteria:

• Other people with mental illness

Related Conditions & MeSH terms

• Non-medicine Intervention
• Schizophrenia

Intervention

Drug:
• non-medicine intervention
rating by MCCB only one time

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai Mental Health Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score of MATRICS Consensus Cognitive Battery		1 day (only one time)